Ultrasonic AccV: a Potential Indicator of Peripheral Arteriosclerosis in Patients with Chronic Obstructive Pulmonary Disease

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2024 Feb 9

PMID 38336639

Authors

Li Lin

Yuting Yan

Bin Jiang

Gang Hou

Yan Yin

Lei Wang

Jian Kang

Qiuyue Wang

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to investigate the risk factors for peripheral arteriosclerosis (PAS) and peripheral artery disease (PAD) in chronic obstructive pulmonary disease (COPD) patients and potential ultrasound indicators that could be used to improve detection.

Method: Outpatients seeking care between January 1, 2017, and December 31, 2020, in The First Affiliated Hospital of China Medical University were prospectively recruited. Subjects were divided into COPD and non-COPD (control) groups, and the COPD group was further divided into PAD and non-PAD subgroup, at the same time, PAS and non-PAS subgroup. Indicators of PAD -ankle-brachial index (ABI), indicators of PAS- pulse wave velocity (PWV), and ultrasound indices -peak systolic blood flow velocity (PSV) and blood flow acceleration velocity (AccV) were compared.

Result: Sixty-nine (61.6%) of 112 enrolled subjects had COPD. COPD patients had higher age, and blood pressure (BP)lower than controls. Seventeen (24.6%) COPD patients had PAD, the prevalence of PAD increases with the decrease of lung function, and seven (16.3%) non-COPD patients had PAD, however, there was no significant statistical difference between COPD and non-COPD groups. Fifty (72.5%) COPD patients had PAS, and thirty-four (79.1%) non-COPD patients had PAS, however, there was also no significant difference. The PAS subgroup had higher age, body mass index(BMI), body fat percentage(BFP), lower FEV1 and FEV1/FVC, as well as higher levels of right brachial artery and left dorsalis pedis artery AccV. Factors that correlated with ABI were 6MWD, post-bronchodilator FEV1, FEV1/ FVC, and maximal middle expiratory flow between 75% and 25% of FVC. Age, BP, and 6MWD, but not pulmonary function, were associated with brachial-ankle PWV (baPWV). There was a positive correlation between baPWV and radial artery AccV bilaterally.

Conclusion: Radial artery AccV correlated well with baPWV, which suggests that ultrasound could be used to assess both morphological and functional changes in vessels, may serving as a better method to identify PAS in high-risk COPD patients.

References

Otsuka K, Nakanishi K, Shimada K, Nakamura H, Inanami H, Nishioka H . Ankle-brachial index, arterial stiffness, and biomarkers in the prediction of mortality and outcomes in patients with end-stage kidney disease. Clin Cardiol. 2019; 42(7):656-662. PMC: 6605000. DOI: 10.1002/clc.23188. View

Urbano L, Portilla E, Munoz W, Hofman A, Sierra-Torres C . Prevalence and risk factors associated with peripheral arterial disease in an adult population from Colombia. Arch Cardiol Mex. 2017; 88(2):107-115. DOI: 10.1016/j.acmx.2017.02.002. View

Lee S, Kim H, Oh B, Choi H, Lee J, Lee S . Association of inter-arm systolic blood pressure differences with arteriosclerosis and atherosclerosis: A cohort study of 117,407 people. Atherosclerosis. 2022; 342:19-24. DOI: 10.1016/j.atherosclerosis.2021.12.003. View

Chandra D, Gupta A, Strollo Jr P, Fuhrman C, Leader J, Bon J . Airflow Limitation and Endothelial Dysfunction. Unrelated and Independent Predictors of Atherosclerosis. Am J Respir Crit Care Med. 2016; 194(1):38-47. PMC: 4960631. DOI: 10.1164/rccm.201510-2093OC. View

Lupilov A, Krause D, Klaassen-Mielke R, Trampisch H, Rudolf H . Effects of Three Different Methods Defining Onset of Peripheral Artery Disease on the Assessments of Incidence and Important Predictors - Results from the German Epidemiological Trial on Ankle Brachial Index (getABI). Vasc Health Risk Manag. 2021; 17:421-429. PMC: 8317934. DOI: 10.2147/VHRM.S307675. View

Zhang P, Ma J, Li D, Li Q, Qi Z, Xu P . The Role of Remnant Cholesterol Beyond Low-Density Lipoprotein Cholesterol in Arterial Stiffness: A Cross-Sectional Study. Metab Syndr Relat Disord. 2023; 21(9):526-534. DOI: 10.1089/met.2023.0101. View

Chen W, Thomas J, Sadatsafavi M, FitzGerald J . Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015; 3(8):631-9. DOI: 10.1016/S2213-2600(15)00241-6. View

Raju S, Brigham E, Paulin L, Putcha N, Balasubramanian A, Hansel N . The Burden of Rural Chronic Obstructive Pulmonary Disease: Analyses from the National Health and Nutrition Examination Survey. Am J Respir Crit Care Med. 2019; 201(4):488-491. PMC: 7049917. DOI: 10.1164/rccm.201906-1128LE. View

Adnot S, Amsellem V, Boyer L, Marcos E, Saker M, Houssaini A . Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential. Pharmacol Ther. 2015; 153:125-34. DOI: 10.1016/j.pharmthera.2015.06.007. View

10.

Pan J, Xu L, Lam T, Jiang C, Zhang W, Zhu F . Relationship between pulmonary function and peripheral vascular function in older Chinese: Guangzhou biobank cohort study-CVD. BMC Pulm Med. 2018; 18(1):74. PMC: 5963074. DOI: 10.1186/s12890-018-0649-x. View

11.

Kuusik K, Kepler T, Zilmer M, Eha J, Vahi M, Kals J . Effects of Remote Ischaemic Preconditioning on Arterial Stiffness in Patients Undergoing Lower Limb Angiographic Procedures: A Randomised Clinical Trial. Eur J Vasc Endovasc Surg. 2019; 58(6):875-882. DOI: 10.1016/j.ejvs.2019.06.004. View

12.

Brusselle G, Bracke K, De Pauw M . Peripheral Artery Disease in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017; 195(2):148-150. DOI: 10.1164/rccm.201608-1712ED. View

13.

Dhanoa D, Baerlocher M, Benko A, Benenati J, Kuo M, Dariushnia S . Position Statement on Noninvasive Imaging of Peripheral Arterial Disease by the Society of Interventional Radiology and the Canadian Interventional Radiology Association. J Vasc Interv Radiol. 2016; 27(7):947-51. DOI: 10.1016/j.jvir.2016.03.049. View

14.

Liu H, Xie W, Liu J, Zhao H, Wu Y, Wang H . Comparison of vascular-related diseases in their associations with carotid femoral pulse wave velocity: From the Beijing Vascular Disease Patients Evaluation Study (BEST Study). Int J Clin Pract. 2019; 73(11):e13400. DOI: 10.1111/ijcp.13400. View

15.

Cardoso C, Melo J, Santos T, Leite N, Salles G . Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Cardiovasc Diabetol. 2021; 20(1):54. PMC: 7912919. DOI: 10.1186/s12933-021-01249-y. View

16.

Gao X, Tong Z, Wu Y, Guo L, Gu Y, Dardik A . Similarities and differences in peripheral artery disease between China and Western countries. J Vasc Surg. 2021; 74(4):1417-1424.e1. DOI: 10.1016/j.jvs.2021.03.030. View

17.

Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C . Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018; 391(10131):1706-1717. DOI: 10.1016/S0140-6736(18)30841-9. View

18.

Alqahtani K, Bhangoo M, Vaida F, Denenberg J, Allison M, Criqui M . Predictors of Change in the Ankle Brachial Index with Exercise. Eur J Vasc Endovasc Surg. 2018; 55(3):399-404. PMC: 5869097. DOI: 10.1016/j.ejvs.2017.12.004. View

19.

Stein R, Hriljac I, Halperin J, Gustavson S, Teodorescu V, Olin J . Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vasc Med. 2006; 11(1):29-33. DOI: 10.1191/1358863x06vm663oa. View

20.

Galani J, Mulder H, Rockhold F, Weissler E, Baumgartner I, Berger J . Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial. Int J Chron Obstruct Pulmon Dis. 2021; 16:841-851. PMC: 8018572. DOI: 10.2147/COPD.S292978. View